Assura (LON:AGR) Share Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Assura Plc (LON:AGRGet Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 48.21 and traded as low as GBX 46.76. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares changing hands.

Wall Street Analysts Forecast Growth

Several research firms have commented on AGR. Shore Capital reiterated a “hold” rating on shares of Assura in a report on Wednesday, October 1st. Peel Hunt reaffirmed a “buy” rating and set a GBX 60 target price on shares of Assura in a report on Tuesday, September 30th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 60.

Get Our Latest Analysis on Assura

Assura Stock Up 0.4%

The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The stock has a market cap of £1.54 billion, a P/E ratio of 895.85, a PEG ratio of 3.60 and a beta of 0.37. The firm has a 50-day simple moving average of GBX 47.48 and a two-hundred day simple moving average of GBX 48.21.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Featured Articles

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.